NY-ESB/WHATSAPP
1.5.2024 01:58:34 CEST | Business Wire | Press release
The Empire State Building (ESB) today unveiled a street-to-Observatory takeover for fans in New York City, in partnership with WhatsApp, that featured an appearance from Mercedes-AMG PETRONAS F1 Team driver Lewis Hamilton, to celebrate WhatsApp’s rapid growth in the United States, dynamic light show, and a street-side F1 car demonstration down New York City’s iconic Fifth Avenue. The chance for F1 fans to participate continues this week with an exclusive opportunity to see firsthand iconic Mercedes-AMG PETRONAS F1 Team cars and an immersive emoji experience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240430558058/en/
Festivities included appearances by Lewis Hamilton and Toto Wolff to the world-famous Empire State Building Observatory and a never-before-seen F1 car demonstration down Fifth Avenue (Photo: Business Wire)
“We are thrilled to use the Empire State Building’s authentic, international voice and for our Observatory to play host to the highest gathering of Mercedes-AMG F1 fans as we welcome guests to experience up-close viewings of the team’s cars and interactive WhatsApp emoji displays at the world-famous Empire State Building Observatory,” said Jean-Yves Ghazi, president of the Empire State Building Observatory. “It is great to welcome Lewis Hamilton and Toto Wolff to this WhatsApp partnership, only at the Empire State Building Observatory Experience,” he continued.
ESB in the Grand Prix
On April 29, ESB debuted a dynamic WhatsApp x Mercedes-AMG F1 race in lights that featured the brand-new emoji race car. The new emoji car zipped through lower Manhattan in a competitive race with other emoji cars and highlighted famous New York City neighborhoods and Emoji-Yorkers decorated around WhatsApp message bubbles. The light display looped on the south side façade from 8:30 p.m. until 10:30 p.m. Lewis Hamilton, driver for the Mercedes-AMG PETRONAS F1 Team along with CEO and Team Principal, Toto Wolff visited the Empire State Building earlier that day to tour the world-famous Observatory Experience and flip the ceremonial switch ahead of the dynamic light show.
Race Through NYC
Earlier this morning, seven-time World Champion Hamilton delighted fans by driving down Fifth Avenue between 35th and 33rd Street in a 2021 Mercedes-AMG F1 W12 E PERFORMANCE. The Brit piloted the W12 to eight Grand Prix victories as the team secured that year’s World Constructors’ Championship.
“I’ve always felt a special connection with the United States,” said Hamilton. “I remember going to New York as a kid and dreaming about living in the city and I’ve been fortunate to spend a lot of time here since then. I’ve had many incredible experiences and connected with many amazing people in New York, but to drive an F1 car down Fifth Avenue and light up the Empire State Building is incredibly special. It’s something I never thought would be possible and it’s been even better to do it in partnership with WhatsApp, an app that keeps my connection to the US alive by making it easy to stay in touch with so many people stateside.”
Welcome to the Paddock
The Empire State Building’s iconic Fifth Avenue Lobby windows now feature special 2D and 3D emoji-themed designs that depict scenes of a Formula 1 garage loaded with tools, tech, and stickers. The window exhibit will remain on display until May 7.
Visitors to the Empire State Building Observatory can view a life-size emoji car and pit stop on the building’s 80th floor. The WhatsApp and Mercedes-AMG F1 branded engineering station will feature versions of the technology that goes into Formula 1 car maintenance. Audio will emulate the noises of a fully functioning F1 car crew. The Empire State Building’s 80th floor will also be adorned with Mercedes-AMG F1 memorabilia which includes three Formula 1 trophies, driver overalls, boots, gloves, and helmet.
Once guests reach the iconic 86th Floor Observatory, fans can pose inside a WhatsApp chat with ESB’s unmatched New York City views as a backdrop and can view a Mercedes-AMG F1 W14 E PERFORMANCE show car, until May 7.
The Empire State Building Observatory recently underwent a $165 million reimagination that included the addition of a dedicated visitor entrance, an immersive museum with nine galleries, brand-new, bespoke Observatory Host uniforms, and a new 102nd Floor Observatory with unmatched view. The reimagined Observatory Experience was recently voted the number one attraction in the U.S. by Tripadvisor travelers for two consecutive years.
Text CONNECT to 274-16 to receive real-time information about the Empire State Building’s tower lights.
Hi-res imagery and video can be found here. More information about the Empire State Building can be found online.
About the Empire State Building
The Empire State Building, the “World's Most Famous Building," owned by Empire State Realty Trust, Inc. (ESRT: NYSE), soars 1,454 feet above Midtown Manhattan from base to antenna. The $165 million reimagination of the Empire State Building Observatory Experience creates an all-new experience with a dedicated guest entrance, an interactive museum with nine galleries, and a redesigned 102nd Floor Observatory with floor-to-ceiling windows. The journey to the world-famous 86th Floor Observatory, the only 360-degree, open-air observatory with views of New York and beyond, orients visitors for their entire New York City experience and covers everything from the building's iconic history to its current place in pop culture. The Empire State Building Observatory Experience welcomes millions of visitors each year and was declared "America's Favorite Building" by the American Institute of Architects, the world's most popular travel destination by Uber, the #1 attraction in the US for the second year in a row in Tripadvisor’s 2023 Travelers’ Choice Awards: Best of the Best, and the #1 New York City attraction in Lonely Planet’s Ultimate Travel List.
Since 2011, the building has been fully powered by renewable wind electricity, and its many floors house a diverse array of office tenants such as LinkedIn and Shutterstock, as well as retail options like STATE Grill and Bar, Tacombi, and Starbucks. For more information and Observatory Experience tickets visit esbnyc.com or follow the building's Facebook, X (formerly Twitter), Instagram, Weibo, YouTube, or TikTok.
Source: Empire State Realty Trust
Category: Observatory
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240430558058/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom